Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Diagnosing aTTP

Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials

The InRange Study

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Time-In-Range (TIR): How to interpret it and how it is associated with outcomes

SoliMix Study Results Summary

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

T1D Treatment Practice and the SAGE Study

Do historical HbA1c values explain glycemic legacy effect in type 2 diabetes?

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

The reason for MS – beyond focal inflammation